Stay updated on JNJ-67856633 and Ibrutinib Combination in B-cell NHL and CLL Clinical Trial
Sign up to get notified when there's something new on the JNJ-67856633 and Ibrutinib Combination in B-cell NHL and CLL Clinical Trial page.

Latest updates to the JNJ-67856633 and Ibrutinib Combination in B-cell NHL and CLL Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe page revision updated from v3.6.2 to v3.6.3, signaling a new build of the page. This update does not alter the study details or data presented.SummaryDifference0.1%

- Check17 days agoChange DetectedPage revision updated from v3.6.0 to v3.6.2, indicating a minor maintenance update to the page's underlying system. No substantive changes to study information or visible content are indicated by this patch.SummaryDifference0.1%

- Check31 days agoChange DetectedRecruitment status now shows the study is not enrolling participants. The page also received minor navigation and formatting adjustments, including new help sections and a standardization of the Intervention/Treatment label and revision history.SummaryDifference0.4%

- Check38 days agoChange DetectedThe page now shows Revision: v3.5.5, replacing the previous Revision: v3.5.4; this indicates a new page build/version and does not alter the study details or eligibility information.SummaryDifference0.1%

- Check59 days agoChange DetectedThe revision label changes from v3.5.3 to v3.5.4, indicating a platform/template update. This metadata update does not appear to alter the displayed study details or content.SummaryDifference0.1%

- Check81 days agoChange DetectedClinicalTrials.gov’s page footer revision label was updated from v3.5.2 to v3.5.3, indicating a site/version change without altering the study details shown.SummaryDifference0.1%

Stay in the know with updates to JNJ-67856633 and Ibrutinib Combination in B-cell NHL and CLL Clinical Trial
Enter your email address, and we'll notify you when there's something new on the JNJ-67856633 and Ibrutinib Combination in B-cell NHL and CLL Clinical Trial page.